<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220403054398N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-10-30</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of compassion therapy on emotional repression and perception of suffering of female patients with vitiligo.</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of treatment on compassion in reducing emotional repression and Perception of the suffering of women with vitiligo undergoing phototherapy.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-11-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/64008</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Other design features: The sample population was divided into two experimental and control groups, and in one group, the intervention (compassion therapy) was implemented, and in the intervention control group, the intervention could not be done, after that, the specified questionnaires were tested in the pre-test and post-test And follow up and analyze, compare and draw conclusions, Randomization description: In order to assign individuals to two experimental groups, the block randomization method was considered by considering blocks 4, 6 and 8. To generate a sequence of random numbers, the web-based software at https://www.sealedenvelope.com/simple-randomiser/v1/lists has been used.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Vitiligo. Condition 2: Perception of Suffering. Condition 3: Emotional Repression.</hc_freetext>
      <i_freetext>Intervention 1: The intervention group of compassion-focused therapy had 8 sessions as two 90-minute sessions in four consecutive weeks, which used techniques (such as: meditation and recognition of emotions and cognitive errors).                       . Description of Compassion-Focused Therapy (CFT) Sessions The first session: establishing initial communication, grouping, overview of the structure of the sessions, getting to know the general principles of CFT therapy and distinguishing compassion from self-pity; Evaluating the amount of emotional abuse, describing and explaining emotional abuse and factors related to its symptoms and conceptualizing self-compassion training. Second session: Mindfulness training along with physical examination and breathing exercises, familiarity with brain systems based on compassion, empathy training; Teaching to understand how people feel to follow things with an empathic attitude and homework.     The third session: getting to know the characteristics of people with compassion, compassion towards others, cultivating a feeling of warmth and kindness towards oneself, cultivating and understanding that others also have defects and problems (cultivating a sense of human commonality) in front of self-destructive feelings and shame, training Sympathy; and providing homework.           The fourth session: reviewing the exercise of the previous session, encouraging the subjects to self-identify and examine their personality as a "compassionate" or "non-compassionate" person according to educational topics, identification and application of "compassionate mind training" exercises (the value of self-compassion, empathy and Compassion towards oneself and others, (physiotherapist metaphor training), forgiveness training and homework.                         Fifth session: review of the exercise of the previous session, familiarity and application of "compassionate mind exercises" (forgiveness, non-judgmental acceptance and tolerance training), training to accept problems. Accepting upcoming changes and enduring difficult and challenging conditions due to the variability of the life process.    The sixth session: review of the exercise of the previous session, practical exercise of creating compassionate images, teaching the styles and methods of expressing compassion (verbal compassion, practical compassion, cross-sectional compassion and continuous compassion) and applying these methods in daily life and for parents, friends, Teachers and acquaintances, teaching the development of valuable and sublime feelings and homework. .             Seventh session: Reviewing the practice of the previous session, teaching how to write compassionate letters for yourself and others, teaching the method of "recording and keeping a diary of real situations based on compassion and the person's performance in that situation".                 The eighth session:training and practicing skills; Reviewing and practicing the skills presented in the previous sessions to help the subjects to deal with the different conditions of their lives in different ways and finally summarizing and providing solutions to maintain and apply this treatment method in everyday life. Intervention 2: Control group: does not receive any treatment.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The result of the article will be available in full.

When:
Taking into account the execution time and the requirements of printing the article, it is expected that 2023 data will be available.

To whom:
Access will be possible for the general researchers.

Conditions:
Conducting further research.

Where to obtain:
Request from authors
Dr. Zainab Arianian
z_aryanian@yahoo.com


Dr. Azam Bayanlou
a.bayanlou@yahoo.com


Saeid Einali
saeideinali.psy@gmail.com

How to obtain:
Requests for data will be sent to researchers and will be sent within two weeks if possible.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zainab Aryanian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Vahdat Islami</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۱۹۹۶۶۳۹۱۱</zip>
        <telephone>+98 21 5563 0553</telephone>
        <email>z_aryanian@yahoo.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zainab Aryanian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Vahdat Islami</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۱۹۹۶۶۳۹۱۱</zip>
        <telephone>+98 21 5563 0553</telephone>
        <email>z_aryanian@yahoo.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Vitiligo diagnosis by the attending physician is a condition for entering the study.
The age range between 18 and 40 years is the condition for entering the study.
Female gender is a condition for entering the study.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>40 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>The use of psychiatric drugs is not included in the study.
Co-occurring with vitiligo is a reason not to enter the study.
Suffering from psychiatric diseases is the reason for not entering the study.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>L80</hc_code>
      <hc_code></hc_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Vitiligo</hc_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The intervention group of compassion-focused therapy had 8 sessions as two 90-minute sessions in four consecutive weeks, which used techniques (such as: meditation and recognition of emotions and cognitive errors).                       . Description of Compassion-Focused Therapy (CFT) Sessions The first session: establishing initial communication, grouping, overview of the structure of the sessions, getting to know the general principles of CFT therapy and distinguishing compassion from self-pity; Evaluating the amount of emotional abuse, describing and explaining emotional abuse and factors related to its symptoms and conceptualizing self-compassion training. Second session: Mindfulness training along with physical examination and breathing exercises, familiarity with brain systems based on compassion, empathy training; Teaching to understand how people feel to follow things with an empathic attitude and homework.     The third session: getting to know the characteristics of people with compassion, compassion towards others, cultivating a feeling of warmth and kindness towards oneself, cultivating and understanding that others also have defects and problems (cultivating a sense of human commonality) in front of self-destructive feelings and shame, training Sympathy; and providing homework.           The fourth session: reviewing the exercise of the previous session, encouraging the subjects to self-identify and examine their personality as a "compassionate" or "non-compassionate" person according to educational topics, identification and application of "compassionate mind training" exercises (the value of self-compassion, empathy and Compassion towards oneself and others, (physiotherapist metaphor training), forgiveness training and homework.                         Fifth session: review of the exercise of the previous session, familiarity and application of "compassionate mind exercises" (forgiveness, non-judgmental acceptance and tolerance training), training to accept problems. Accepting upcoming changes and enduring difficult and challenging conditions due to the variability of the life process.    The sixth session: review of the exercise of the previous session, practical exercise of creating compassionate images, teaching the styles and methods of expressing compassion (verbal compassion, practical compassion, cross-sectional compassion and continuous compassion) and applying these methods in daily life and for parents, friends, Teachers and acquaintances, teaching the development of valuable and sublime feelings and homework. .             Seventh session: Reviewing the practice of the previous session, teaching how to write compassionate letters for yourself and others, teaching the method of "recording and keeping a diary of real situations based on compassion and the person's performance in that situation".                 The eighth session:training and practicing skills; Reviewing and practicing the skills presented in the previous sessions to help the subjects to deal with the different conditions of their lives in different ways and finally summarizing and providing solutions to maintain and apply this treatment method in everyday life.</i_keyword>
      <i_keyword>Control group: does not receive any treatment.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The score of the Weinberger Adaptability Questionnaire (WAI) . Timepoint: Before the start of the intervention, after the end of the intervention, one month after the end of the intervention. Method of measurement: Weinberger Adaptability Questionnaire (WAI).</prim_outcome>
      <prim_outcome>The score of the Scholz Suffering Questionnaire. Timepoint: Before the start of the intervention, after the end of the intervention, one month after the end of the intervention. Method of measurement: Scholz Suffering Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name>Shahab Danesh University.</sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
      <source_name>Shahab Danesh University.</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-08-30</approval_date>
        <contact_name>Research Ethics Committee of Medical School-Tehran University of Medical Sciences</contact_name>
        <contact_address>No.12, Vahdat Eslami Ave. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
